Loading…
← Back to schedule
Panel: Strategic Insights: Navigating Biotech M&A and Dealmaking Landscape in 2024 and Beyond
Tuesday October 1, 2024 12:15pm - 1:00pm EDT
This panel is designed to provide strategic insights and actionable intelligence for navigating the evolving landscape of biotech M&A and dealmaking in 2024 and beyond.
  • Examine the latest trends shaping biotech M&A activities, including deal sizes, strategic motivations, and market dynamics.
  • Discuss the impact of recent M&A transactions on the industry landscape and competitive positioning.
  • Predict and discuss strategic insights for dealmakers, including potential deal structures, sector-specific opportunities, and regulatory considerations for 2025 and beyond.
  • Evaluate the impact of M&A and dealmaking activities on biotech innovation, R&D pipelines, and industry growth.
Speakers
SC

Shaan C. Gandhi, MD, DPhil

Head of Strategic Partnerships, Pfizer Ignite
avatar for Fred Chereau

Fred Chereau

SVP, Strategy & Business Development, Alexion, AstraZeneca Rare Disease
Fred brings close to 30 years of biotech, pharmaceutical, and medical device experience to Alexion, where he oversees strategy and business development activities. Prior to joining Alexion, he served as president and chief executive officer of LogicBio. Previously, Fred served as... Read More →
Tuesday October 1, 2024 12:15pm - 1:00pm EDT
  Track: Strategy & Dealmaking

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Share Modal

Share this link via

Or copy link